Mesenchymal Stem Cells for Cardiac Regeneration: Translation to Bedside Reality
Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the World Health Organization (WHO), an estimate of 17.3 million people died from CVDs in 2008 and by 2030, the number of deaths is estimated to reach almost 23.6 million. Despite the development of a variety of treat...
Saved in:
| Main Authors: | Mohammad T. Elnakish, Fatemat Hassan, Duaa Dakhlallah, Clay B. Marsh, Ibrahim A. Alhaider, Mahmood Khan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2012/646038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From bench to bedside: translating mesenchymal stem cell therapies through preclinical and clinical evidence
by: Jai Chand Patel, et al.
Published: (2025-07-01) -
Advancements in lung regeneration: from bench to bedside
by: Danial Khayatan, et al.
Published: (2025-02-01) -
The role of mesenchymal stem cells in peripheral nerve regeneration
by: N. M. Nevmerzhytska, et al.
Published: (2024-08-01) -
Application of mesenchymal stem cells in liver fibrosis and regeneration
by: Zhenyu Liu, et al.
Published: (2024-12-01) -
Tissue engineering strategies for ocular regeneration; from bench to the bedside
by: Zeinab Mousavi, et al.
Published: (2024-10-01)